Vera M Abeler
Overview
Explore the profile of Vera M Abeler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
715
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nielsen B, Hveem T, Kildal W, Abeler V, Kristensen G, Albregtsen F, et al.
Cytometry A
. 2014 Dec;
87(4):315-25.
PMID: 25483227
Nuclear texture analysis measures the spatial arrangement of the pixel gray levels in a digitized microscopic nuclear image and is a promising quantitative tool for prognosis of cancer. The aim...
2.
Micci F, Haugom L, Abeler V, Davidson B, Trope C, Heim S
BMC Cancer
. 2014 Jun;
14:315.
PMID: 24886194
Background: It is known that all tumors studied in sufficient number to draw conclusions show characteristic/specific chromosomal rearrangements, and the identification of these chromosomes and the genes rearranged behind the...
3.
Kraggerud S, Hoei-Hansen C, Alagaratnam S, Skotheim R, Abeler V, Rajpert-De Meyts E, et al.
Endocr Rev
. 2013 Apr;
34(3):339-76.
PMID: 23575763
This review focuses on the molecular characteristics and development of rare malignant ovarian germ cell tumors (mOGCTs). We provide an overview of the genomic aberrations assessed by ploidy, cytogenetic banding,...
4.
Micci F, Panagopoulos I, Haugom L, Dahlback H, Pretorius M, Davidson B, et al.
Genes Chromosomes Cancer
. 2013 Feb;
52(6):551-63.
PMID: 23404381
Little is known about the genomic abnormalities of squamous cell carcinomas (SCC) of the vulva and how they correlate with gene expression. We determined the genomic and expression profiles of...
5.
Trope C, Abeler V, Kristensen G
Acta Oncol
. 2012 Jul;
51(6):694-705.
PMID: 22793037
Background: The histopathological classification and staging system for uterine sarcoma (US) were revised in 2003 and 2009, respectively. However, there is currently no consensus on the significance of various prognostic...
6.
Nielsen B, Albregtsen F, Kildal W, Abeler V, Kristensen G, Danielsen H
Anal Cell Pathol (Amst)
. 2012 May;
35(4):305-14.
PMID: 22596183
Background: Nuclear texture analysis gives information about the spatial arrangement of the pixel gray levels in a digitized microscopic nuclear image, providing texture features that may be used as quantitative...
7.
Kildal W, Micci F, Risberg B, Abeler V, Kristensen G, Heim S, et al.
Mol Oncol
. 2011 Nov;
6(1):98-107.
PMID: 22062770
DNA ploidy analysis is useful for prognostication in cancer patients, but the genomic details underlying ploidy changes are not fully understood. To improve this understanding, we compared DNA ploidy status...
8.
Abeler V, Nenodovic M
Int J Gynecol Pathol
. 2011 Apr;
30(3):236-43.
PMID: 21464730
The purpose of this study was to evaluate the use of a broad panel of antibodies used as diagnostic markers for abdominal mesenchymal tumors in uterine sarcomas. The expression of...
9.
Micci F, Skotheim R, Haugom L, Weimer J, Eibak A, Abeler V, et al.
Genes Chromosomes Cancer
. 2010 Aug;
49(11):1046-53.
PMID: 20725991
Alterations of chromosome 19 are among the most frequent cytogenetic changes in ovarian carcinomas. They usually occur as added extra material of unknown origin to 19p or, less frequently, 19q...
10.
Micci F, Haugom L, Ahlquist T, Andersen H, Abeler V, Davidson B, et al.
J Transl Med
. 2010 Feb;
8:21.
PMID: 20184781
Background: According to the scientific literature, less than 30 borderline ovarian tumors have been karyotyped and less than 100 analyzed for genomic imbalances by CGH. Methods: We report a series...